Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (171-180 of 607) with videos related to

Pageof 61
Sort By:
Progress in Lipid Research|January 1, 1981
Relationships between prostaglandins, prostacyclin and EFA precursors in rabbits maintained on EFA-deficient dietsA L Willis, A G Hassam, M A Crawford, et al.
Clinical Radiology|August 23, 2008
The role of radiology in the management of systemic sclerosisG Madani, R D Katz, J A Haddock, et al.
Clinical Immunology (Orlando, Fla.)|February 17, 2019
Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosisCorrado Campochiaro, Simon Lytton, Svetlana Nihtyanova, et al.
Rheumatology Advances in Practice|April 22, 2024
Testing a candidate composite serum protein marker of skin severity in systemic sclerosisElen Roblin, Kristina E N Clark, Claire Beesley, et al.
The American Journal of Gastroenterology|November 17, 2011
Fecal incontinence in systemic sclerosis is secondary to neuropathyNora M Thoua, Mostafa Abdel-Halim, Alastair Forbes, et al.
Plastic and Reconstructive Surgery|March 26, 2025
Long-term outcome of fat grafting to treat facial Systemic Sclerosis: a prospective cohort studyAurora Almadori, Michelle Griffin, Jeon Hyun, et al.
Rheumatology (Oxford, England)|September 15, 2005
Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin scoreM Dziadzio, R E Smith, D J Abraham, et al.
Rheumatology (Oxford, England)|August 31, 2015
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosisJasmin Raja, Svetlana I Nihtyanova, Charles D Murray, et al.
Thrombosis and Haemostasis|February 6, 2015
Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditionsGerhard Dickneite, Heiko Herwald, Wolfgang Korte, et al.
Rheumatology (Oxford, England)|March 18, 2021
Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patientsYasir Suleman, Kristina E N Clark, Alice R Cole, et al.
Pageof 61

Showing results (171-180 of 607) with videos related to

Sort By:
Pageof 61
Progress in Lipid Research|January 1, 1981
Relationships between prostaglandins, prostacyclin and EFA precursors in rabbits maintained on EFA-deficient dietsA L Willis, A G Hassam, M A Crawford, et al.
Clinical Radiology|August 23, 2008
The role of radiology in the management of systemic sclerosisG Madani, R D Katz, J A Haddock, et al.
Clinical Immunology (Orlando, Fla.)|February 17, 2019
Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosisCorrado Campochiaro, Simon Lytton, Svetlana Nihtyanova, et al.
Rheumatology Advances in Practice|April 22, 2024
Testing a candidate composite serum protein marker of skin severity in systemic sclerosisElen Roblin, Kristina E N Clark, Claire Beesley, et al.
The American Journal of Gastroenterology|November 17, 2011
Fecal incontinence in systemic sclerosis is secondary to neuropathyNora M Thoua, Mostafa Abdel-Halim, Alastair Forbes, et al.
Plastic and Reconstructive Surgery|March 26, 2025
Long-term outcome of fat grafting to treat facial Systemic Sclerosis: a prospective cohort studyAurora Almadori, Michelle Griffin, Jeon Hyun, et al.
Rheumatology (Oxford, England)|September 15, 2005
Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin scoreM Dziadzio, R E Smith, D J Abraham, et al.
Rheumatology (Oxford, England)|August 31, 2015
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosisJasmin Raja, Svetlana I Nihtyanova, Charles D Murray, et al.
Thrombosis and Haemostasis|February 6, 2015
Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditionsGerhard Dickneite, Heiko Herwald, Wolfgang Korte, et al.
Rheumatology (Oxford, England)|March 18, 2021
Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patientsYasir Suleman, Kristina E N Clark, Alice R Cole, et al.
Pageof 61